BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2605974)

  • 1. Circulating immune complexes in patients with hematologic diseases.
    Yen JH; Liu HW; Lin SF; Chen TP; Chang CS; Liu TC; Tsai WJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):138-44. PubMed ID: 2605974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte complement receptor type I in patients with hematologic diseases.
    Yen JH; Liu HW; Lin SF; Chen TP
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):186-92. PubMed ID: 2532592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Hayashi S; Aochi H; Nagamine K; Oshida M; Mizutani H; Tomiyama Y; Tsubakio T; Yonezawa T; Tarui S
    Clin Exp Immunol; 1987 Feb; 67(2):293-9. PubMed ID: 3608226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes in chronic thrombocytopenic purpura in adults before and after splenectomy].
    Podolak-Dawidziak M; Kuliszkiewicz-Janus M; Kielan W; Weryńska B; Niewolna M
    Pol Arch Med Wewn; 1989; 82(4-6):175-83. PubMed ID: 2534975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathologic changes in the thymus gland in several diseases of the hematopoietic organs].
    Shurygin DIa; Sidorov KA; Mishchenko AS
    Klin Med (Mosk); 1971 May; 49(5):31-5. PubMed ID: 5291077
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
    Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
    Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of circulating immune complexes in some diseases associated with a platelets hyperdestruction process (author's transl)].
    Goudemand J; Santoro F
    Pathol Biol (Paris); 1978 Oct; 26(7):435-9. PubMed ID: 372899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in acute leukemia.
    Cermák J; Feyereislová A; Horejsí J
    Neoplasma; 1989; 36(1):21-7. PubMed ID: 2704422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes in patients with malignant neoplasms].
    Vel'bri SK; Lindstrem SL; Varik MIa
    Vopr Onkol; 1986; 32(6):34-9. PubMed ID: 3088837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
    Snyder HW; Balint JP; Jones FR
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of immunoadsorption therapy by a protein A column on patients with thrombocytopenia.
    Muroi K; Sasaki R; Miura Y
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):10-4. PubMed ID: 2658094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.
    Patel GV; Gopal R; Nadkarni JJ
    Cancer Immunol Immunother; 1985; 20(1):80-4. PubMed ID: 3877562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
    Bosly A; Keating MJ; Stasi R; Bradstock K
    Anticancer Drugs; 2002 Nov; 13 Suppl 2():S25-33. PubMed ID: 12710588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology due to immuno-complexes in hematology (author's transl)].
    Gavosto F; Caligaris Cappio F
    Haematologica; 1979 Oct; 64 Suppl():249-58. PubMed ID: 161539
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
    Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
    Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of circulating immune complexes in some diseases associated with platelets hyperdestruction process (author's transl)].
    Goudemand J; Santoro F
    Sem Hop; 1979 Jan 18-25; 55(3-4):198-202. PubMed ID: 219529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiplatelet antibody and circulating immune complexes in patients with idiopathic thrombocytopenic purpura].
    Kurata Y; Hayashi S; Oshida M; Tsubakio T; Yonezawa T
    Rinsho Ketsueki; 1985 Feb; 26(2):177-83. PubMed ID: 4040583
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.